000 | 01108 a2200313 4500 | ||
---|---|---|---|
005 | 20250511180109.0 | ||
264 | 0 | _c19920713 | |
008 | 199207s 0 0 eng d | ||
022 | _a0941-0198 | ||
024 | 7 |
_a10.1007/BF00422944 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGehr, G | |
245 | 0 | 0 |
_aCytokines, receptors, and inhibitors. _h[electronic resource] |
260 |
_bThe Clinical investigator _cJan 1992 |
||
300 |
_a64-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aCytokines _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-1 _xphysiology |
650 | 0 | 4 |
_aReceptors, Cell Surface _xphysiology |
650 | 0 | 4 |
_aReceptors, Immunologic _xantagonists & inhibitors |
650 | 0 | 4 | _aReceptors, Interleukin-1 |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aBraun, T | |
700 | 1 | _aLesslauer, W | |
773 | 0 |
_tThe Clinical investigator _gvol. 70 _gno. 1 _gp. 64-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00422944 _zAvailable from publisher's website |
999 |
_c1324649 _d1324649 |